SpiceJet Share Price Rises 6.20%; Promoter Group to Infuse ₹294 Crore into SpiceJet

On March 17, 2025, SpiceJet announced that its Founder and Promoter, Ajay Singh, through M/s Spice Healthcare Private Limited, will inject ₹294.09 crore into the airline. 

This infusion will be executed through the conversion of 13.14 crore warrants into an equivalent number of equity shares. As a result, the Promoter Group’s consolidated shareholding in SpiceJet will rise from 29.11% to 33.47%.

Amidst the announcement, on March 17, 2025, SpiceJet share price opened at ₹45.20, almost the same as its previous close of ₹45.48. At 10:19 AM, the share price of SpiceJet was trading at ₹48.30, up by 6.20% on the BSE.

Partial Stake Sale by Promoter to Fund Infusion

To facilitate this investment, Ajay Singh will sell up to 3.15 crore equity shares of SpiceJet. The proceeds from this sale will be used to partially fund the balance of 75% of the amount required for the allotment of equity shares following the warrant conversion.

Strengthened Promoter Commitment

This capital infusion highlights the Promoter Group’s confidence in SpiceJet’s long-term growth prospects and strategic direction. It is expected to strengthen the airline’s financial position, supporting its ongoing operations and expansion plans.

Upcoming Board Approval

A Board/Committee meeting is scheduled to be held on or before March 18, 2025, to approve the allotment of shares under the warrant conversion option. This step will formalise the equity structure changes and reinforce the airline’s capital base.

Commenting on this, the Chairman and Managing Director of SpiceJet, Ajay Singh, said, “This fresh infusion reaffirms our unwavering commitment to the airline and its bright future. This investment will further strengthen our financial position and drive growth. SpiceJet has always been a resilient airline, and with this fresh capital, we are well positioned to enhance our operations and seize new opportunities.”

Conclusion

The company stated that the successful conversion of warrants and subsequent capital infusion marks another significant step in SpiceJet’s ongoing turnaround strategy.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.